Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's Wuxi PharmaTech Signs New Agreement On Toxicology Studies Training And Services With J&J Unit

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Just days after disclosing that a newly launched drug safety testing center had been accredited by a U.S. group, leading Chinese contract research organization Wuxi PharmaTech signed a toxicology deal with Johnson & Johnson Pharmaceutical Research & Development
Advertisement

Related Content

From Biologics To Corporate Venture, China's Leading CRO Continues To Evolve
From Biologics To Corporate Venture, China's Leading CRO Continues To Evolve
Fresh Off BMS Deal, Leading Chinese CRO WuXi PharmaTech Outlines Plan To Expand Biologics Business To Keep Pace With Big Pharma
Fresh Off BMS Deal, Leading Chinese CRO WuXi PharmaTech Outlines Plan To Expand Biologics Business To Keep Pace With Big Pharma
WuXi PharmaTech Rebounds; Prepares For A Surge In China Biologics
WuXi PharmaTech Rebounds; Prepares For A Surge In China Biologics
WuXi PharmaTech Disappointed With Charles River Breakup; Faces Toxicology Field Alone
WuXi PharmaTech Disappointed With Charles River Breakup; Faces Toxicology Field Alone
Wuxi PharmaTech Obtains Humane Animal Treatment Accreditation For Toxicology Facility In Eastern China
Wuxi PharmaTech Obtains Humane Animal Treatment Accreditation For Toxicology Facility In Eastern China
Advertisement
UsernamePublicRestriction

Register

SC074323

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel